100%(50)50 out of 50 people found this document helpful
This preview shows page 1 - 2 out of 3 pages.
Week 8 Initial Discussion Post DiscussionDecision Making When Treating Psychological DisordersThe psychological disorder selected for this week’s discussion post was Bipolar Disorder in a 26-year-old Korean female. She presented to the clinic after a 21-day hospitalization for onset of acute mania. She arrives to the office dressed in evening attire, and her speech is rapid, pressured, and tangential. She is unable to sit still during the interview as she reports having a “fantastic” mood and decreased need for sleep due to sleep not being “fun”. She admits that she does not believe that she has bipolar because she just likes to “talk, dance, and cook”. She reportsbeing prescribed Lithium while she was hospitalized, but admits that she stopped taking this medication once she was discharged. These initial assessment behaviors represent those similar to a bipolar, manic or euphoric state. Manic episodes are characterized by heightened or irritable moods that are often associated with hyperactivity, excessive enthusiasm, flight of ideas, and a reduced need for sleep (Rosenthal & Burchum, 2018). Patients with bipolar disorder can often present with varying mood behaviors, and these situations often occur in cycles of unsafe and even risky behavior. Patients can also experience periods of comparably normal moods in-between manic or depressive episodes, which can make adherence to treatment difficult. Pharmacotherapeutic Impact on Patient PathophysiologyThe first treatment plan decision was to begin Lithium 300 mg orally BID. Research suspects that bipolar disorder may be caused by a neurotransmitter imbalance, or by disruption of neuronal growth and survival. Mood-stabilizing drugs can prevent or reverse neuronal atrophy inpatients with bipolar disorder by influencing the signaling pathways that regulate neuronal growth and survival (Rosenthal & Burchum, 2018). Lithium has been effective for